Constructive news tone
News Sentiment
TEVAN sentiment intelligence
Teva Pharmaceutical Industries Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
65
Constructive news tone
4 relevant articles
News tone and price action are not far from neutral.
62/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +9.2% over four weeks, trend active, and materially above fair value.
Teva Pharmaceutical Advances Neuroscience Pipeline With Strong AUSTEDO Growth & New Acquisition
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
62/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend active
9.2% over four weeks
Fair value
77.1%
Materially above fair value
Sentiment confirms active trend
Positive but stretched
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
2
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Streetwise Reports
Direct company coverage
Teva Pharmaceutical Advances Neuroscience Pipeline With Strong AUSTEDO Growth & New Acquisition
- Tone
- Positive 82/100
- Event
- Deals and strategy
- Published
- 17 Jun 2026 09:11
- Source
- Streetwise Reports
IndexBox
Direct company coverage
Teva Pharmaceutical Biosimilar Growth and Market Outlook 2026 - News and Statistics
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 12 Jun 2026 20:50
- Source
- IndexBox
Market source
Direct company coverage
Why Teva Pharmaceuticals (TEVA) Crashed on Wednesday?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jan 2025 08:00
- Source
- Market source
PR Newswire
Direct company coverage
Allergan plc Completes Divestiture of Global Generics Business to Teva Pharmaceuticals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Aug 2016 07:00
- Source
- PR Newswire